PrismHR-Logos_HEX__Color.png
UPDATE -- PrismHR Receives 2023 CSO50 Award
July 19, 2023 11:19 ET | PrismHR
HOPKINTON, Mass., July 19, 2023 (GLOBE NEWSWIRE) -- PrismHR, the leading HR technology software powering payroll, benefits, and HR for businesses across the U.S., today shared that it has been named...
Jeannie Walters, CCXP
Leading Customer Experience Authority to Headline PrismHR LIVE
June 21, 2023 07:00 ET | PrismHR
HOPKINTON, Mass., June 21, 2023 (GLOBE NEWSWIRE) -- Jeannie Walters, CCXP, the award-winning customer experience expert, international keynote speaker, and Founder of Experience Investigators, will...
ScottStratten
UnMarketing Founder Scott Stratten to Keynote PrismHR LIVE 2023
June 01, 2023 07:00 ET | PrismHR
HOPKINTON, Mass., June 01, 2023 (GLOBE NEWSWIRE) -- Award-winning keynote speaker known for his energy, passion, and knowledge – Scott Stratten – will be featured at this year’s PrismHR LIVE 2023 in...
PrismHR-Logos_HEX__Color.png
Exhibitors and Sponsors Flock to PrismHR LIVE 2023, This Year’s Premier Event for HR Service Providers
May 23, 2023 07:00 ET | PrismHR
HOPKINTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- PrismHR, the leading HR technology software powering payroll, benefits, and HR for businesses across the U.S., today shared additional details...
01_PrimaryLogo_Color_BlueX-100.jpg
Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy Day
April 27, 2022 08:25 ET | Praxis Precision Medicines, Inc.
BOSTON, April 27, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
01_PrimaryLogo_Color_BlueX-100.jpg
Praxis Precision Medicines to Present Data from Rare Disease Programs at the American Epilepsy Society 2021 Annual Meeting
November 29, 2021 08:00 ET | Praxis Precision Medicines, Inc.
BOSTON, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...